Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from QT Imaging Holdings ( (QTI) ) is now available.
On February 25, 2026, QT Imaging Holdings, Inc. reported that it had posted a new investor presentation on its website, offering supplemental product and operational information about the company and its breast imaging technology. The materials, furnished rather than filed under U.S. securities rules, emphasize that they are informational in nature and not an indication of materiality, while outlining non-GAAP financial metrics and extensive cautionary language around forward-looking statements and associated risks.
The company also highlighted prior U.S. Food and Drug Administration clearance from June 6, 2017, confirming its QT Breast Scanner as substantially equivalent to a predicate device. By consolidating regulatory context, financial metrics definitions, and risk disclosures, the presentation is designed to frame investor expectations around QT Imaging’s technology platform, commercial rollout, and financial reporting approach without altering its formal SEC filing obligations.
The most recent analyst rating on (QTI) stock is a Buy with a $10.00 price target. To see the full list of analyst forecasts on QT Imaging Holdings stock, see the QTI Stock Forecast page.
Spark’s Take on QTI Stock
According to Spark, TipRanks’ AI Analyst, QTI is a Neutral.
The score is held down primarily by very weak financial performance (persistent losses and cash burn with historically fragile equity), partially offset by a strong recent corporate update pointing to accelerating revenue, improved losses, and strengthened financing. Technicals are neutral and valuation remains unattractive due to negative earnings.
To see Spark’s full report on QTI stock, click here.
More about QT Imaging Holdings
QT Imaging Holdings, Inc. operates in the medical imaging sector with a focus on breast health diagnostics. The company develops and commercializes its Quantitative Transmission Imaging Breast Acoustic CT Scanner, aiming to provide advanced, non-ionizing imaging solutions for precision breast screening and diagnosis across healthcare markets.
Average Trading Volume: 23,744
Technical Sentiment Signal: Hold
Current Market Cap: $67.96M
See more data about QTI stock on TipRanks’ Stock Analysis page.